Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

Objectives

To evaluate the tolerability and safety of increasing doses of primaquine in combination with artemether-lumefantrine in G6PD deficient males with an asymptomatic P. falciparum malaria infection

PI Institution(s)

Principal Investigator (PI)

Partner(s)

https://clinicaltrials.gov/ct2/show/NCT02174900

Key facts

  • Dates
    Oct 2014 to Sep 2015
    Country
    • Burkina Faso

MESA tags

  • Methodology
    Operational research, Product development & clinical research
    Theme(s)
    Drug-based strategies, Tools for elimination